Navigation Links
BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research
Date:6/19/2013

LARKSPUR, Calif., June 19, 2013 /PRNewswire/ -- BioCision, a leader in advanced products to improve sample standardization and handling in many areas of medical and scientific research, announced today the issuance of new patents by the U.S. Patent Office that apply to two of the company's thermo-conductive products developed to standardize sample handling to ensure the consistency of test conditions and accuracy of results in common laboratory procedures.

Patent number 8,388,912 covers CoolSink® Plate Modules, which provide a solid, sturdy interface between laboratory sample plates and a heat sink, such as ice, or a heat source. The modules are made of a thermo-conductive alloy that maintains an even temperature across all wells in the plate, eliminating any "edge effect" where content from the wells close to the perimeter of the plate change temperature more rapidly than those in the center of the plate. This helps maintain samples at a desired temperature while keeping them dry and sterile, which are optimal conditions for ELISA, multiplex immunoassays, enzyme assays, and cell washing steps.

In addition, BioCision's ThermalTray™ Platforms were awarded patent number 8,460,621. The platforms support sample racks or plates in liquid and semi-solid heat sinks and sources such as melting ice, water baths, and liquid nitrogen. Eliminating direct contact between a sample tube or plate and melting ice or bath water protects against potential water-borne contaminants. The platforms are made of a thermo-conductive alloy, assisting in the transfer of heat between samples and a temperature source.

"These new patents reflect the innovation and new opportunities to improve sample standardization that our products represent," said Rolf Ehrhardt, MD, PhD, BioCision CEO. "This patent protection provides significant support for our continuing efforts to help research institutions in the biotechnology, pharmaceutical, clinical, diagnostic, academic, and government scientific communities to set entirely new standards for performance in sample handling."

Ensuring reproducible temperature profiles and standardizing temperature-sensitive lab procedures are essential goals in a wide array of scientific disciplines, including cell and tissue culture, cryopreservation, histology, immunohistochemistry, virus and bacterial research, molecular biology, cell therapy, pharmaceutical manufacturing, biofuels research and many others.  Advances in technology to control temperature in sample handling can improve accuracy of test results, which can have a direct impact on diagnosis and patient outcomes.  In addition, improvements in sample standardization can improve the ability of researchers around the world to replicate important research results.

About BioCision, LLC

BioCision is a leading provider of innovative tools for standardizing sample and biomaterial handling, cryopreservation and storage procedures. BioCision products are used worldwide by researchers in the pharmaceutical, biotechnology, academic and health care industries. For more information visit www.biocision.com, or visit the BioCision blog for news and expert insight at http://blog.biocision.com/. Follow @BioCision on Twitter and "Like" the BioCision Facebook page at https://www.facebook.com/BioCisionLLC.


'/>"/>
SOURCE BioCision
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... July 10, 2017  BDI Group subsidiary Pathway ... support services organization serving specialty pharmacies, home infusion ... of four significant, value-added member programs designed to ... manage reimbursement and improve access and affordability for ... Pathway ...
(Date:7/10/2017)... 10, 2017 Locus Biosciences Inc. today announced ... the development of CRISPR-Cas3 antimicrobial therapeutics. Financing for the ... Chinese Internet services provider, and joined by the North ... disease product programs targeting antibiotic resistant infections and other ... by Dr. Rodolphe Barrangou and Dr. ...
(Date:7/5/2017)... , July 5, 2017 Wolfmet 3D  printed ... as physics and manufacturing combine to progress molecular radiotherapy imaging. ... SPECT systems are unable to accurately quantify the radiation absorbed ... information regarding the success of this radiotherapy treatment has been ... ...
Breaking Medicine Technology:
(Date:7/20/2017)... ... ... Buffalo and Her Adventures”: a collection of heartwarming children’s stories. “Lucky the Buffalo and ... was born in Toledo, Ohio. He attended Woodward High School. He earned an ... a brilliant woman with a caring heart named Tiina, who is a hospice nurse. ...
(Date:7/18/2017)... ... 18, 2017 , ... Cognition Corporation , a software ... sessions of its “From the Helm” Webinar Series. , These sessions will ... Cognition’s CEO, the half-hour public webinars will take an in-depth look at applying ...
(Date:7/18/2017)... Calif. (PRWEB) , ... July 18, 2017 , ... The results of an international clinical ... a drug therapy for a severe type of muscular dystrophy holds promise for a subgroup ... , Craig McDonald and colleagues at 53 study sites in 18 countries describe ...
(Date:7/18/2017)... ... July 18, 2017 , ... An inventor from Anacortes, Wash., knows ... menopause, I have frequent hot flashes, and I suffer from anxiety and vertigo on ... keep cool while out and about." INSTA-FAN meets that need. , This device enables ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... Heritage Woods ... from 11 a.m. to 12:30 p.m. on Aug. 15. , The community, which is ... including those on Medicaid, who need some help to maintain their independence. , The ...
Breaking Medicine News(10 mins):